Recombinant IL6 (Olokizumab Biosimilar) antibody

Catalog No. ABIN7487956

This anti-IL6 (Olokizumab Biosimilar) antibody is a Mammalian Cells Monoclonal antibody detecting IL6 (Olokizumab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for Recombinant IL6 (Olokizumab Biosimilar) antibody (ABIN7487956)

Target: IL6 (Olokizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL6 (Olokizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL6 (Olokizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Olokizumab Biosimilar - Anti-IL6 mAb

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL6 (Olokizumab Biosimilar)

Target: IL6 (Olokizumab Biosimilar)

Target Type: Biosimilar

Background: CDP 6038
Olokizumab is an immunomodulator. It binds to interleukin 6. Hence acting as an Anti-IL-6 therapeutic aimed at inflammatory disease e.g. rheumatoid arthritis (RA).

CAS-No: 1007223-17-7